Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03391414 · ClinicalTrials.gov registry record · Phase 1
Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis
A Phase 1 study of Cystic Fibrosis, sponsored by Joseph Pilewski.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT03391414 is a Phase 1 study of Cystic Fibrosis that has completed, run by Joseph Pilewski. The registered enrollment target is 12 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03391414, a Phase 1 study of Cystic Fibrosis, has completed, sponsored by Joseph Pilewski.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is possible to decrease the acidity of the airways by inhaling sodium bicarbonate through nebulizer treatments.
Conditions Studied
Interventions
- DRUG hypertonic bicarbonate
- DRUG sodium chloride
Study Locations (2)
Pennsylvania
- UPMC Fallk Clinic - Pittsburgh
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03391414
The ClinicalTrials.gov registry entry for NCT03391414 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (93% lower). The listed sponsor is Joseph Pilewski, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 2 interventions - of which hypertonic bicarbonate is the first listed.
NCT03391414 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03391414 about?
NCT03391414 is a clinical study titled "Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis". This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is po...
What is the current status of trial NCT03391414?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-08. Estimated completion is 2016-07.
What conditions does trial NCT03391414 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT03391414?
The interventions under investigation include: hypertonic bicarbonate (DRUG), sodium chloride (DRUG).
Who is sponsoring clinical trial NCT03391414?
This trial is sponsored by Joseph Pilewski, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03391414 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
RECRUITING · Phase 1
-
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
RECRUITING · Phase 1
-
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
RECRUITING · Phase 1
-
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
RECRUITING · Phase 1
-
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.